An ALS diagnosis almost always satisfies the medical criteria for a viatical settlement, allowing a patient to sell a life insurance policy for a lump sum that is typically far above its cash surrender value — and, because ALS commonly supports a terminal-illness certification, the proceeds are often income-tax-free under IRC Section 101(g). The disease’s heavy equipment, home-modification, and caregiving costs make liquidity urgent, yet timing and capacity planning matter more with ALS than with almost any other diagnosis. Families should always obtain the carrier’s accelerated death benefit quote before selling, since that route can preserve part of the death benefit for beneficiaries.
This guide covers qualification, pricing, taxes, the special role of powers of attorney, and how a viatical settlement fits alongside VA, SSDI, and Medicare resources available to ALS families.
In This Article
- ALS and the Viatical Framework: A Near-Automatic Medical Fit
- The Cost Curve of ALS — and Why Liquidity Timing Matters
- How Providers Price an ALS Policy
- Taxes: Terminal vs. Chronic Certification Changes the Answer
- Capacity, Communication, and the Power of Attorney Question
- How a Settlement Interacts With SSDI, Medicare, Medicaid, and VA Benefits
- The Alternatives: ADB Riders, Loans, and Keeping the Policy
- Frequently Asked Questions

ALS and the Viatical Framework: A Near-Automatic Medical Fit
Amyotrophic lateral sclerosis occupies an unusual position in settlement underwriting: it is one of the few diagnoses that reliably satisfies both doorways into a viatical transaction.
The terminal illness doorway requires a physician certification that life expectancy is roughly 24 months or less. Median survival with ALS runs two to five years from symptom onset, and because diagnosis often follows symptoms by a year or more, many patients meet the 24-month standard at or soon after diagnosis — particularly with bulbar-onset disease or rapid functional decline. Underwriters track markers such as forced vital capacity, ALSFRS-R scores, feeding tube placement, and ventilation decisions.
The chronic illness doorway requires certified inability to perform two or more activities of daily living without substantial assistance. ALS’s progressive loss of motor function means nearly every patient crosses this threshold during the disease course, often well before the terminal certification applies.
Which doorway applies is not academic — it drives tax treatment, as discussed below. Beyond the medical picture, the ordinary policy tests still apply: coverage in force two-plus years, face value generally $100,000 or more (with flexibility for clearly terminal files), and a permanent policy or convertible term. There is no minimum age, which matters for a disease with median onset in the mid-50s and many patients diagnosed in their 30s and 40s. Full criteria are covered in who qualifies for a viatical settlement.
The Cost Curve of ALS — and Why Liquidity Timing Matters
ALS is frequently described as one of the most expensive diseases a family can face, and the costs arrive in a distinctive pattern: they escalate as function declines, which is precisely when many income sources have already stopped.
- Mobility and equipment: power wheelchairs with custom seating, transfer lifts, hospital beds, and communication devices (speech-generating technology) — much of it partially covered at best, with long approval queues.
- Home modification: ramps, widened doorways, roll-in showers, and first-floor living conversions, which insurance rarely covers.
- Vehicle adaptation: wheelchair-accessible vans commonly cost as much as a new car even before adaptation.
- Caregiving: the largest line item over time. As the disease progresses, families move from part-time help to round-the-clock care, and a spouse frequently leaves work — a double income loss.
- Ventilation decisions: non-invasive ventilation and, for families who choose it, tracheostomy with invasive ventilation carry substantial ongoing costs.
This cost curve explains why ALS families investigate viatical settlements earlier in the disease course than cancer families typically do. A settlement completed while the patient can still participate in decisions, sign documents, and direct how funds are used is administratively simpler and personally more meaningful than one executed later through an agent. Families weighing how to fund care generally should also review using life insurance to pay for long-term care for the wider set of tools.
How Providers Price an ALS Policy
Settlement offers are discounted cash flow calculations: projected premiums out, death benefit in, discounted at the buyer’s required return. The controlling variable is the life expectancy estimate — the shorter it is, the fewer premiums the buyer pays and the sooner it collects, so the more it can offer. That mechanism is unpacked in life expectancy and settlement pricing.
For ALS specifically, underwriters at the firms that produce independent life expectancy reports look at:
- Onset type and progression rate. Bulbar-onset disease and rapid ALSFRS-R decline shorten estimates; slower limb-onset progression lengthens them.
- Respiratory function. Falling forced vital capacity is among the strongest mortality predictors in ALS underwriting.
- Nutritional status — weight trajectory and feeding tube placement.
- Ventilation choices. A patient who elects tracheostomy and invasive ventilation may live years longer, which underwriters must model; this personal medical decision genuinely interacts with settlement value and is worth understanding before offers are sought.
- Time since diagnosis relative to typical survival curves.
For scale: the GAO’s market study found ordinary settlements paying 10–35% of face value and four to eight times surrender value. ALS files certified as terminal typically price above that band, and several states impose minimum viatical payout percentages tied to life expectancy. Multiple bids from licensed providers remain the only reliable way to discover a specific policy’s value; no outcome is ever guaranteed.
| Program / Resource | Means-Tested? | Effect of Viatical Lump Sum | ALS-Specific Note |
|---|---|---|---|
| SSDI | No | None | Compassionate Allowances listing; five-month waiting period waived for ALS |
| Medicare | No | None | Immediate eligibility with SSDI — the standard 24-month wait is waived for ALS |
| Medicaid (incl. home-care waivers) | Yes | Countable asset; can suspend eligibility until spent down | Often funds caregiving hours Medicare will not; sequence settlement carefully |
| VA disability compensation | No | None | ALS is presumptively service-connected for qualifying veterans |
| VA needs-based pension | Yes | Can breach asset limits | Review with a VA-accredited advisor before funds arrive |
| Accelerated death benefit rider | No (contract right) | — | Check before selling; terminal and chronic triggers both fit ALS |

Taxes: Terminal vs. Chronic Certification Changes the Answer
Because ALS patients can qualify under either the terminal or the chronic illness definition, the tax analysis deserves unusual care.
Terminal certification — the clean exclusion. Under IRC Section 101(g), viatical proceeds received by an insured whom a physician has certified as having a life expectancy of 24 months or less are treated as death benefits — generally excluded from gross income entirely, with no cap and no restriction on how the money is used. For most ALS patients who meet the 24-month standard, this is the controlling rule.
Chronic certification — conditional relief. A patient certified as chronically ill (two-plus ADL deficits) but not terminal receives a narrower exclusion: amounts are generally tax-free only to the extent used for qualified long-term care expenses not reimbursed elsewhere, or within an annually adjusted per-diem limit. Above those bounds, taxation can apply.
The practical guidance follows directly: if the medical facts support a terminal certification, obtain it in writing before closing. The physician’s statement, plus confirmation that the purchaser is a licensed viatical settlement provider (verifiable through your state insurance department — in New Jersey, the NJ DOBI), is what secures the full exclusion. Sellers who qualify under neither definition would face the standard three-tier treatment of IRS Rev. Rul. 2009-13, described in our tax treatment guide. The complete statutory detail lives in the viatical settlement tax exclusion article, and personal advice should come from a tax professional familiar with your full picture.
Capacity, Communication, and the Power of Attorney Question
ALS presents a planning consideration that most other viatical diagnoses do not: while cognition typically remains intact (a minority of patients develop frontotemporal impairment), the physical ability to sign documents, speak on the phone, and manage paperwork declines steadily. Transactions have a lot of paperwork; ALS families should plan for that collision early.
- Execute a durable power of attorney now, not later. A POA drafted while the patient can sign — ideally with explicit authority over life insurance transactions, which some states and most providers look for — lets a spouse or adult child execute settlement documents seamlessly if hand function is lost mid-process. Waiting until signing is physically impossible forces messier alternatives.
- Signature accommodations exist. Notaries can administer signature-by-mark, and some states permit directed signatures; but these add friction and scrutiny that a clean POA avoids.
- Communication access. Providers must verify the seller’s voluntary consent. Speech-generating devices and letter boards are workable, but building extra time into calls and confirming everything in writing protects everyone.
- HIPAA releases. The medical record authorizations described in our guide to records releases should be signed early, alongside the POA, in one document-execution session while it is easiest.
Trust-owned policies sidestep some of this — the trustee signs — but the insured’s cooperation on medical releases is still needed. An elder law or special-needs attorney experienced with neurodegenerative disease is a worthwhile early investment, and typically also helps with the Medicaid questions discussed below.
How a Settlement Interacts With SSDI, Medicare, Medicaid, and VA Benefits
ALS patients hold an unusual public-benefits position, and a viatical lump sum lands differently on each program.
- SSDI — unaffected. ALS is on the Social Security Administration’s Compassionate Allowances list, and Congress eliminated the usual five-month SSDI waiting period for ALS. SSDI is an earned insurance benefit, not means-tested, so settlement proceeds do not touch it. Details are at ssa.gov.
- Medicare — unaffected. Uniquely, ALS patients receive Medicare immediately upon SSDI entitlement, without the standard 24-month wait. Medicare has no asset test.
- Medicaid — directly affected. Many families rely on Medicaid for the home-care hours Medicare will not cover. Medicaid is means-tested, and a viatical lump sum is a countable asset that can suspend eligibility until properly spent down. Sequence matters enormously: read settlements and Medicaid spend-down and involve an elder law attorney before funds arrive, not after.
- VA benefits — potentially affected on the pension side. ALS is a presumptively service-connected condition for veterans, entitling many to disability compensation (not means-tested) through the VA. Needs-based VA pension programs, by contrast, do carry asset limits that a lump sum can breach.
The planning takeaway: a viatical settlement pairs naturally with SSDI and Medicare, requires careful sequencing around Medicaid, and calls for a benefits review for veterans. None of this argues against selling — it argues for ordering the steps deliberately.
The Alternatives: ADB Riders, Loans, and Keeping the Policy
A viatical settlement is one tool among several, and state disclosure law — built on the NAIC model framework — requires that sellers be informed of the alternatives before closing. For ALS families the checklist looks like this:
- Accelerated death benefit rider — check first. Many policies pay 25–75% or more of the death benefit directly from the carrier upon terminal illness certification, and some include chronic illness acceleration triggered by ADL loss — a natural fit for ALS. The ADB is faster, simpler, and preserves the unaccelerated remainder for beneficiaries. Its caps and carrier discounting are the trade-off. Start with our accelerated death benefit guide and get the carrier’s quote in writing.
- Policy loans and withdrawals. Permanent policies with meaningful cash value can fund near-term costs without selling; the loan simply reduces the eventual death benefit.
- Keeping the policy in force. If premiums are manageable and the family’s greatest need is the eventual death benefit — a surviving spouse’s income replacement, for instance — holding may serve best. If premiums are the obstacle, these options for premium hardship come before any lapse.
- Hybrid sequencing. Some families accelerate part of the benefit through an ADB rider, then later evaluate selling the remainder — carrier rules on post-acceleration sales vary and must be checked.
The disciplined comparison is always the same: carrier ADB quote, actual net viatical offers, loan capacity, and the value of holding — laid side by side with taxes, timing, and what each path leaves for family. Our complete viatical guide provides the full decision framework.
Frequently Asked Questions
Does an ALS diagnosis automatically qualify me for a viatical settlement?
Nearly, but not automatically. ALS reliably satisfies the medical criteria — most patients meet either the terminal-illness standard (physician-certified life expectancy of roughly 24 months or less) or the chronic-illness standard (inability to perform two or more activities of daily living) at some point in the disease course. The policy still has to qualify too: generally in force two-plus years, face value around $100,000 or more, and permanent coverage or convertible term. Age is irrelevant.
Are viatical settlement proceeds tax-free for ALS patients?
Usually, when the terminal-illness certification applies. IRC 101(g) treats proceeds paid to an insured certified with a life expectancy of 24 months or less as death benefits — generally fully excluded from income, with no spending restrictions. Patients certified only as chronically ill get a narrower exclusion tied to qualified long-term care expenses and per-diem caps. If your medical facts support terminal certification, obtain it in writing before closing, and confirm the buyer is a state-licensed provider.
When in the course of ALS should a family consider a viatical settlement?
Earlier than most expect — not necessarily to sell early, but to prepare early. Completing a durable power of attorney, gathering policy documents, and getting the carrier’s accelerated death benefit quote while the patient can easily sign and communicate keeps every option open. Costs also escalate with progression (equipment, home modification, caregiving), so many families seek offers around the time major expenses become concrete. Waiting until signing is physically difficult adds friction without adding value.
Will a viatical settlement affect SSDI or Medicare for someone with ALS?
No. SSDI is an earned, non-means-tested benefit — and ALS patients receive it on an expedited basis with the five-month waiting period waived — so a lump sum has no effect. Medicare, which ALS patients uniquely receive immediately upon SSDI entitlement rather than after 24 months, has no asset test either. The program to watch is Medicaid, which is means-tested and often funds home-care hours; settlement proceeds are countable and require spend-down planning first.
How does choosing a ventilator affect a viatical settlement for ALS?
It can matter materially. Tracheostomy with invasive ventilation can extend survival by years, and life expectancy underwriters must model that choice — a longer projected survival generally means a lower offer, and could move a file from terminal to chronic classification, changing tax treatment. This is first and foremost a personal medical decision made with your care team. But families should understand the financial interaction and consider the timing of underwriting relative to major care decisions.
Can my spouse complete the viatical settlement if I can no longer sign documents?
Yes, with the right authority in place. A durable power of attorney executed while you could sign — ideally granting explicit authority over life insurance transactions — allows your spouse or another agent to execute settlement documents on your behalf. Providers scrutinize POA language, so have it drafted by an attorney familiar with your state’s requirements. Without a POA, alternatives like guardianship are slow and costly. Signing the POA and HIPAA releases early is the single best preparation step.
Is an accelerated death benefit better than a viatical settlement for ALS?
Sometimes, and you should always price it first. Many policies include terminal illness riders paying 25–75% of the death benefit directly from the carrier, and some include chronic illness riders triggered by ADL loss — both fit ALS. The ADB is faster and preserves the remaining death benefit for your family, but caps and carrier discounting limit it. A viatical sale can produce more total cash but surrenders the entire benefit. Compare the written ADB quote against real net offers.
Do veterans with ALS have additional options before selling a policy?
Yes. ALS is presumptively service-connected, so veterans with qualifying service are generally entitled to VA disability compensation — a significant monthly, non-means-tested benefit — plus VA health care, equipment, and caregiver support. These resources can reduce the cash pressure that drives policy sales, or complement a settlement. Note that needs-based VA pension programs do have asset limits a lump sum can breach. A VA-accredited representative can review entitlements before you make irreversible policy decisions.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- Viatical Settlement Complete Guide
- Who Qualifies Viatical Settlement
- Chronic Illness Accelerated Death Benefit
- Paying For Long Term Care Life Insurance
Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.